Alongside its 3Q21 results reporting, Colfax provided an update on its progression from a provider of diversified technologies to a medtech company.
Colfax announced its acquisition of DJO in late 2018. In early 2021, the company divulged its intention to split into two public companies by the first quarter of 2022. The Fabrication Technology segment will be spun off to Colfax shareholders. At that time, Colfax and DJO will transition to its new name, Enovis.
The resulting medical technology company's leadership team will include Matt Trerotola (CEO), Brady Shirley (COO) and Chris Hix (CFO) - all current Colfax executives.
Colfax has made strong progress integrating its recent acquisitions of foot and ankle products (MedShape, Trilliant Surgical and Stryker’s STAR total ankle) as well as Mathys, developer of products for joint replacement, synthetic bone graft solutions and sports medicine into DJO. Acquisitions will continue to be an important part of the company’s strategy to shape its medical technology business for faster growth.